I'm a title. Click here to add your own text and edit me.
Our core team at Hyperbolic Holdings represents a cohesive and complimentary global outlook with decades of combined experience. We can help you navigate the ever changing landscape of healthcare and life sciences, giving you insights and access to the most exciting developments as they happen. Our combined business and industry experience, our accrued relationships and contacts, help you to make considered investments to create long term value
EUGENE DURENARD Phd
Founder & CEO
Eugene has an investment and entrepreneurial experience spanning 20 years. For the last 7 years he has been working
with family offices on direct investments and philanthropy focused on life sciences. He serves on the board of
Co-Diagnostics (CODX on Nasdaq) and advisory boards of Regenerative Medical Solutions, Calviri and Vaxxit. He advises Global Impact Solutions Today (GIST) on impactful investments in healthcare.
After an initial career in proprietary research and trading at Saloman Brothers and Credit Suisse in London, he co-founded Orion Investment Management in Bermuda specializing in quantitative asset and liability management for institutions and private clients. He subsequently sold it to Capital G Bank and co-headed their asset management.
Eugene spent several years establishing personal connections with representatives of 40+ clusters of life science innovation, families operating healthcare businesses and industry leaders globally. He regularly visits labs and incubators, meets with leading scientists and innovators in order to keep abreast of current trends and developments.
His advice is based on a thorough analysis that combines in-depth knowledge of science, competitive forces and financial expertise.
He has a PhD in Mathematics from Harvard University.
Richard is Partner of Fabase, a life sciences holding company. Richard is former COO of the Gorlin Group of Companies,
LLC, a family office specializing in life science investments.
He serves as Managing Director of platform Health Ventures, a healthcare strategic and tactical consulting group.
Richard is a pharmacist, regulatory attorney and patent attorney.
He was Chief FDA Counsel for Revlon Corporation and Johnson & Johnson Corporation.
During his career he served as the lead in taking two companies public and co-founded over ten companies.
Richard is the Chairman of Eu Yan Sang International. He joined the family business in 1989, was group CEO from
2002 until 2017, and transformed it into one of the largest Traditional Chinese Medicine businesses worldwide
operating 250 retail stores and clinics.
Richard was named the E&Y Entrepreneur of the Year 2011 and the Singapore CEO of the Year in 2010.
Richard sits on the boards of BIGL Group, Reliance Asset Management, Dragonfly Education.
He is trustee of the Singapore University of Social Sciences and the ThyeHua Kuan Moral Charities group.